ARCHIVES

FDA Issues Final Rules On Patient Access To Investigational Drugs

This article is from The Cancer Letter archive.

Vol. 35 No. 33 | September 11, 2009

Download PDF Visit The Full Archive

Related Articles

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

NIH Clinical Center Offers Sabbatical In Clinical Research Management

October 1, 2010

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

In Brief: Allegra To Head NCI/Navy Branch; Sausville Promoted; Gladstein To Leave NCI For Dallas

October 25, 1991

Funding Opportunities: Lymphoma Foundation Offers Two-Year Fellowship Grants

July 31, 1998

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996